Glutaric Acid → 5-{4-[3-(5-Chloro-thiazol-2-yl)-1-cyclohexyl-ureido]-piperidin-1-yl}-5-oxo-pentanoic acid

HRID 253934

반응식

HRID 253934 반응식
[Cl:1][C:2]1[S:6][C:5]([NH:7][C:8](=[O:23])[N:9]([C@H:16]2[CH2:21][CH2:20][C@H:19](C)[CH2:18][CH2:17]2)[CH:10]2[CH2:15][CH2:14][NH:13][CH2:12][CH2:11]2)=[N:4][CH:3]=1.[C:24](O)(=[O:31])[CH2:25][CH2:26][CH2:27][C:28]([OH:30])=[O:29]>>[Cl:1][C:2]1[S:6][C:5]([NH:7][C:8](=[O:23])[N:9]([CH:10]2[CH2:15][CH2:14][N:13]([C:24](=[O:31])[CH2:25][CH2:26][CH2:27][C:28]([OH:30])=[O:29])[CH2:12][CH2:11]2)[CH:16]2[CH2:17][CH2:18][CH2:19][CH2:20][CH2:21]2)=[N:4][CH:3]=1

참가 물질

3

실험 절차

Prepared as described in general procedure (G) using 3-(5-chloro-thiazol-2-yl)-1-(trans-4-methyl-cyclohexyl)-1-piperidin-4-yl-urea and glutaric acid

후처리

  1. customPrepared

출처 및 근거

ORD 기록
ord-564a17e4142241629deeaced507bfb76
출처 데이터셋
uspto-grants-2011_01
특허 번호
US07872139B2

연결된 노트

불러오는 중…